Your browser doesn't support javascript.
loading
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients.
Betof Warner, Allison; Tarhini, Ahmad; Kang, Barinder; Nakasato, Antonio; Ling, You-Li; Shah, Rohan; Tang, Jackson; Patel, Jeetvan.
Afiliação
  • Betof Warner A; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Tarhini A; Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Kang B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Nakasato A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Ling YL; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Shah R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Tang J; Asclepius Analytics Ltd., New York, New York, USA.
  • Patel J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Melanoma Res ; 33(1): 38-49, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36545921
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article